Emerging β-Amyloid Therapies for the Treatment of Alzheimers Disease
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
427-447
Author(s):
Kelly A. Conway, Ellen W. Baxter, Kevin M. Felsenstein and Allen B. Reitz
Drug Metabolism and Individualized Medicine
Journal:
Current Drug Metabolism
Volume:
4
Page:
33-44
Author(s):
Pratima Srivastava
Receptor-Based Design of Cytokine Therapeutics
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
1-20
Author(s):
A. B. Shanafelt
Diabetes Gene Therapy: Potential and Challenges
Journal:
Current Gene Therapy
Volume:
3
Page:
65-82
Author(s):
Ruian Xu, Hua Li, Tse Lai-yin, Kung Hsiang-fu, Hongyan Lu and Karen S. L. Lam
Gastrointestinal Disturbances in Anorexia Nervosa and Bulimia Nervosa
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
2
Page:
1-9
Author(s):
Sallie Jo Hadley and B. Timothy Walsh
Emerging Drug Toxicities of Highly Active Antiretroviral Therapy for HumanImmunodeficiency Virus (HIV) Infection
Journal:
Current Drug Targets
Volume:
4
Page:
13-22
Author(s):
K. V. Heath, J. S.G. Montaner, G. Bondy, J. Singer, M. V. O'Shaughnessy and R. S. Hogg
Selective Carbohydrate Recognition by Synthetic Receptors in Aqueous Solution
Journal:
Current Organic Chemistry
Volume:
7
Page:
81-102
Author(s):
Susanne Striegler
Study of the cis-trans Isomerization of the Amino-Acyl prolyl Peptide Bond. Application to the Design of Novel Inhibitors of Immunophilins
Journal:
Current Organic Chemistry
Volume:
6
Page:
1397-1431
Author(s):
Christophe Dugave
Are Gap Junction Channels a Therapeutic Target and if so What Properties are Best Exploited?
Journal:
Current Drug Targets
Volume:
3
Page:
417-425
Author(s):
Peter R. Brink
Challenges for Gene Therapy of Type 1 Diabetes
Journal:
Current Gene Therapy
Volume:
2
Page:
403-414
Author(s):
H. Dong, K. Anthony and N. Morral